London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Scart I think that was a good idea. In parallel with that I’ve contacted the likes of Proactive and said they should be getting Vlad into do another interview. The more of us that do that, we might build some momentum.
@JHFH after @lunus' success I emailed them yesterday :'-D suggesting that they start getting a bit more active with the media e.g. Proactive, Vox, Share Talk etc. to get in front of more investors and really sell what HEMO is doing. I'm sure there are probably some restrictions due to Globalco secrecy but who knows - figured it was worth a prod anyway but hoping they're already on it tbh
I think the HEMO website is actually quite informative now and if anyone took the time to read the Chairman’s statement it tells you all you need to know. Sure they could improve the investor relations side but that will come as they expand their employees and start getting revenue in.
Oh yes and what WaitingRoom said. Hemogenyx are not actively selling themselves to investors at present, probably because they are too busy and SP will come when they start revealing the licencing contracts with up front payments etc, but they definitely could do a better job selling what they do and the potential revenue streams coming.
The simple answer is that we don’t have a CEO or Chairman that can put a clear case of why our technology demands a high valuation (Mcap) to shareholders. If you compare to AVCT, their CEO is constantly ‘promoting’ the technology in clear terms and making it clear how each product development builds value. They also have some ‘independent’ researchers (Myles) that are giving their own view of how MCap and future value is built up.
I would dearly love someone in HEMO to work on the helicopter view, but I think they are so involved (as academics often are) in the boiler room. Maybe need someone on the bridge.
Lol I wish you were right RE manipulation but unfortunatly the MMs have until recently been very capable of shaking shares any time there was a big order to fill, and they always fill them by lowering the price. In terms of the low SP there are a few factors: 1, There WAS a pump and dump, think the partially used covid even though hemo at that point had just mentioned something covid related with no details 2, We have had shorters selling borrowed stock to drop the price, no idea if still in or position closed, I suspect still in but hard to know 3, We have had ALOT of day traders, just in for the 5% and selling every time they got it dropping the sp on their way out. 4, We had an RNS stating a 3 month extension to the Global Co agreement
That said, the negative gone, heres the positives: 1, Broken the downward spiral, we have started moving up slowly 2, The pump and dumpers are gone, most investors now are here to hold, still some traders but most shareholders can atleast spell hemogenyx now, before they had no idea what the company was or did. 3, The anonomus Global co is believed with very strong evidence to be Pfizer 4, The 3 month extension is about up, looks like Pfizer are about to announce start of Phase 1 human trials with the CDX antibody which will come with it massive reward for hemo.
My view is that there is little of actual substance just yet that can actually add value to the company. Everything is in the pipeline but at this stage, it is in a sense still speculation. What I mean is....there is a chance , until proved otherwise with positive confirmations by the BOD, that the various projects may fail. Highly unlikely, but still possible. So there is as yet, not much i n the way of actual guaranteed earnings. That is my view only. If anyone has a a better view then I'm happy to be corrected. There is always something to learn!
I'm a holder here and massively positive - check my post history - but one things concerns me a little...why are we struggling to hold onto 6p? We had a 15p spike on very little but with all the positive news flow since a relatively small placing we are really struggling? The market always knows, nothing is a surprise. This is main market to so manipulation is less so.
I must admit I have thoroughly enjoyed these message boards over the past 24 hours. Not only has it given me invaluable information about which I am most grateful, but it has also kept me very entertained. Tempted to add a few more.
GlobalCo will be a big deal whomever it is. Covid not going anywhere sadly and until a working vaccine is produced (if even possible) then antibody treatment and regular testing will have a significant part to play.
HEMOs ApbHC mice are a biodefense platform in their own right. We will have been amongst the fastest responders to the pandemic. We know we can quickly build a isolate antibodies, build a disease model to test them on and prove up efficacy and toxicology on our GVH-free mice. The results should be compelling. I think we will know soon.
IMO. Perhaps the GlobalCo rationale is just to firewall against the known collaborations, such as Janssen (J&J). With the continuing Covid situation in the USA, this is everyone’s priority from a US perspective; I see it on a daily basis living near Detroit. Most of the big pharmas have research labs in either in the Tri-State area (like Hemo, Pfizer vaccines, J&J etc) or Boston (Moderna). Only today on NBC Pfizer’s vaccine was described as having ‘neutralizing antibody‘ effects. Media speak I know. All supposition I know, but as usual I am in the waiting room.
From a corporate perspective we've worked on it and we've found we have had success with modelling the virus and isolating antibodies then suddenly is a great 'quick win'.
Think about it. The other projects take time to develop and perfect then you come across something you can deliver on in months. We have been on a biodefense platform since last year with the mice so why wouldn't be in a position to attack covid in a live exercise!!!
100% agree with you both, Covid play is coming first I believe, I had a feeling it would be today or tomorrow but looks like not today. Would be great if its a 7am tomorrow drop, not a fan of afternoon friday RNS. But thats just a hunch, no proof of anything Covid related, its really very hush hush and believe me I have looked!!! Could come tomorrow, could come in a week or so, its going to be a surprise to us all! (Well maybe not Vlad, I think he knows the score :P) I threw in the Global Co reveal because I was relieved to finally prove it to myself, but like I said, to me the name is irrelevant, its a big name yea but I already knew that.
Although long term investors have continually played down HEMOs covid play I am starting to get the feeling we might just have something that can be commercialised for Covid. Anyone else been thinking this?
Whilst talk of the GlobalCo announcement dominates the horizon and what the amazing CDX might be worth as it moves to human trials, we are still working on a COVID antibody risk rating test that could maybe act as a traffic light assessment on an individuals prevalence to get seriously sick from Covid. This would be a serious breakthrough! With extra funding now available we have been told that projects such as this can be significantly speeded up so is it fair to assume the historic timescales on delivering on project developments will be significantly reduced?
Vlad has a passion for saving lives and helping humanity. I believe he's thrown the kitchen sink at this and based on our track record of successful milestones I can see us producing the goods once again on the covid project and sooner rather than later.
Although we announced the commencement of the covid project in April I believe we have been working on it much longer. I suspect news on this front could well be imminent. Surely you would want to release it with a healthy gap between it and the GlobalCo announcement for full effect?